Scope Of Practice: Pharmacist Perspectives On Plaque Psoriasis

Reviewed by Editorial Team
The ProProfs editorial team is comprised of experienced subject matter experts. They've collectively created over 10,000 quizzes and lessons, serving over 100 million users. Our team includes in-house content moderators and subject matter experts, as well as a global network of rigorously trained contributors. All adhere to our comprehensive editorial guidelines, ensuring the delivery of high-quality content.
Learn about Our Editorial Process
| By Robert Macgregor
R
Robert Macgregor
Community Contributor
Quizzes Created: 1 | Total Attempts: 280
| Attempts: 280
SettingsSettings
Please wait...
  • 1/11 Questions

    Most provinces have expanded scope of practice and reimbursed pharmacist services which can be integrated to improve the quality of life for the psoriatic patient.

    • True
    • False
Please wait...
Scope Of Practice: Pharmacist Perspectives On Plaque Psoriasis - Quiz
About This Quiz

This quiz explores pharmacist perspectives on plaque psoriasis, focusing on prevalence, age of onset, associated risks such as cardiovascular disease, and management guidelines. It assesses understanding of treatment applications and patient compliance, crucial for effective therapy selection.

Quiz Preview

  • 2. 

    Mixing of bases or adding ingredients may reduce the potency and shelf-life of some formulations.

    • True

    • False

    Correct Answer
    A. True
    Explanation
    Mixing of bases or adding ingredients to formulations can indeed reduce their potency and shelf-life. This is because certain ingredients or combinations of ingredients may chemically interact with each other, leading to degradation or loss of efficacy. Additionally, introducing new ingredients can introduce potential contaminants or alter the stability of the formulation. Therefore, it is important to carefully consider the compatibility of ingredients and follow proper formulation guidelines to maintain the potency and shelf-life of a product.

    Rate this question:

  • 3. 

    Side effects of topical corticosteroids include skin atrophy, stretch marks, and/or adrenal gland suppression.

    • True

    • False

    Correct Answer
    A. True
    Explanation
    Topical corticosteroids are commonly used to treat various skin conditions. However, they can have side effects when used for prolonged periods or in high doses. Skin atrophy refers to the thinning of the skin, while stretch marks are caused by the weakening of the skin's elasticity. Adrenal gland suppression occurs when the body's natural production of cortisol is reduced due to the use of corticosteroids. These side effects are well-documented and can occur with the use of topical corticosteroids, making the statement true.

    Rate this question:

  • 4. 

    The central theme of the Canadian Guidelines for the Management of Plaque Psoriasis is that physicians (prescribers) should not only choose therapies that work, but those that the patient will work with.

    • True

    • False

    Correct Answer
    A. True
    Explanation
    The central theme of the Canadian Guidelines for the Management of Plaque Psoriasis is that physicians should consider not only the effectiveness of therapies but also the patient's willingness to adhere to them. This implies that treatment decisions should take into account the patient's preferences, lifestyle, and ability to comply with the prescribed therapies. By selecting treatments that the patient will work with, physicians can improve treatment outcomes and patient satisfaction.

    Rate this question:

  • 5. 

    Psoriasis patients do not have an increased risk of inflammatory disease and depression.

    • True

    • False

    Correct Answer
    A. False
    Explanation
    Psoriasis is a chronic inflammatory skin condition, and research has shown that patients with psoriasis are at an increased risk of developing inflammatory diseases such as cardiovascular disease, metabolic syndrome, and psoriatic arthritis. Additionally, studies have also found a higher prevalence of depression among psoriasis patients compared to the general population. Therefore, the statement that psoriasis patients do not have an increased risk of inflammatory disease and depression is false.

    Rate this question:

  • 6. 

    Psoriasis is not a risk factor for cardiovascular disease.

    • True

    • False

    Correct Answer
    A. False
    Explanation
    Psoriasis is actually considered a risk factor for cardiovascular disease. Several studies have shown a strong association between psoriasis and an increased risk of developing cardiovascular conditions such as heart disease, stroke, and high blood pressure. The chronic inflammation associated with psoriasis is believed to contribute to the development of cardiovascular problems. Additionally, certain risk factors such as obesity, smoking, and a sedentary lifestyle, which are common in individuals with psoriasis, further increase the risk of cardiovascular disease. Therefore, the statement that psoriasis is not a risk factor for cardiovascular disease is false.

    Rate this question:

  • 7. 

    One fingertip unit of psoriasis topical cream, ointment or gel is equal to:

    • 1 g of cream/ointment/gel, covering an area the size of one side of the patient’s hand

    • 0.5 g of cream/ointment/gel, covering an area the size of one side of the patient’s hand

    • 1 g of cream/ointment/gel, covering an area the size of two sides of the patient’s hand

    • 0.5 g of cream/ointment/gel, covering an area the size of two sides of the patient’s hand

    Correct Answer
    A. 0.5 g of cream/ointment/gel, covering an area the size of one side of the patient’s hand
    Explanation
    One fingertip unit of psoriasis topical cream, ointment, or gel is equal to 0.5 g of cream/ointment/gel, covering an area the size of one side of the patient's hand. This means that the patient should apply half a gram of the product, which is enough to cover the area of one side of their hand.

    Rate this question:

  • 8. 

    The two main age ranges for initial onset and diagnosis of psoriasis are:

    • Early teens and again in the 70s

    • Late teens to early adulthood and again in the 70s

    • Late teens to early adulthood and again in the late 50s to early 60s

    • Late 30s and again in the late 50s to early 60s

    Correct Answer
    A. Late teens to early adulthood and again in the late 50s to early 60s
    Explanation
    Psoriasis typically first appears in late teens to early adulthood, which is the most common age range for initial onset and diagnosis. However, there is also a second peak in the late 50s to early 60s, where the condition can reoccur or worsen in individuals who had psoriasis earlier in life or developed it for the first time during this age range.

    Rate this question:

  • 9. 

    What is the prevalence of psoriasis in the general population?

    • 2%

    • 5%

    • 7%

    • 10%

    Correct Answer
    A. 2%
    Explanation
    The correct answer is 2% because psoriasis is a common chronic skin condition that affects approximately 2% of the general population. It is characterized by red, scaly patches on the skin and can vary in severity. While the prevalence may vary among different populations and regions, 2% is a widely accepted estimate for the overall prevalence of psoriasis in the general population.

    Rate this question:

  • 10. 

    Which of the following is not a potential trigger for psoriasis:

    • Warm weather

    • Alcohol consumption

    • Streptococcal infection

    • Emotional stress

    Correct Answer
    A. Warm weather
    Explanation
    Psoriasis is an autoimmune skin condition that is triggered by various factors. Warm weather is not a potential trigger for psoriasis because it is generally believed that sunlight and ultraviolet (UV) rays can actually improve the symptoms of psoriasis. UV rays can slow down the rapid growth of skin cells, which is a characteristic of psoriasis. Therefore, warm weather is not considered a trigger for psoriasis.

    Rate this question:

  • 11. 

    In calcipotriol/betamethasone diproprionate therapy, marked improvement or clearance is generally seen:

    • Within 2 weeks

    • Within 3 weeks

    • Within 4 weeks

    • After 6 weeks

    Correct Answer
    A. Within 4 weeks
    Explanation
    In calcipotriol/betamethasone diproprionate therapy, marked improvement or clearance is generally seen within 4 weeks. This means that patients can expect to see significant improvement in their condition within a month of starting the treatment. It is important to note that individual responses may vary, but the majority of patients experience noticeable improvement within this timeframe.

    Rate this question:

Quiz Review Timeline (Updated): Mar 20, 2023 +

Our quizzes are rigorously reviewed, monitored and continuously updated by our expert board to maintain accuracy, relevance, and timeliness.

  • Current Version
  • Mar 20, 2023
    Quiz Edited by
    ProProfs Editorial Team
  • Feb 11, 2014
    Quiz Created by
    Robert Macgregor
Back to Top Back to top
Advertisement
×

Wait!
Here's an interesting quiz for you.

We have other quizzes matching your interest.